(FM) Medicina Interna
Departamento académico
Alfredo
Martínez Hernández
Investigador fins a 2023
Publicacions en què col·labora amb Alfredo Martínez Hernández (46)
2024
2023
-
Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome
Biomedicine and Pharmacotherapy, Vol. 161
-
Corrigendum: Role of NAFLD on the health related QoL response to lifestyle in patients with metabolic syndrome: The PREDIMED plus cohort(Front. Endocrinol., (2022), 13, (868795), 10.3389/fendo.2022.868795)
Frontiers in Endocrinology
-
Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset
European Journal of Clinical Investigation, Vol. 53, Núm. 10
-
Repercussions of absolute and time-rated BMI “yo-yo” fluctuations on cardiovascular stress-related morbidities within the vascular-metabolic CUN cohort
Frontiers in Endocrinology, Vol. 13
2022
-
A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers
Panminerva medica, Vol. 64, Núm. 4, pp. 485-496
-
Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicine
Current Opinion in Clinical Nutrition and Metabolic Care, Vol. 25, Núm. 5, pp. 285-291
-
Hematological-and Immunological-Related Biomarkers to Characterize Patients with COVID-19 from Other Viral Respiratory Diseases
Journal of Clinical Medicine, Vol. 11, Núm. 13
-
Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events
Journal of Clinical Medicine, Vol. 11, Núm. 17
-
Longitudinal association of dietary acid load with kidney function decline in an older adult population with metabolic syndrome
Frontiers in Nutrition, Vol. 9
-
Longwise Cluster Analysis for the Prediction of COVID-19 Severity within 72 h of Admission: COVID-DATA-SAVE-LIFES Cohort
Journal of Clinical Medicine, Vol. 11, Núm. 12
-
Machine learning insights concerning inflammatory and liver-related risk comorbidities in non-communicable and viral diseases
World Journal of Gastroenterology, Vol. 28, Núm. 44, pp. 6230-6248
-
Morbid liver manifestations are intrinsically bound to metabolic syndrome and nutrient intake based on a machine-learning cluster analysis
Frontiers in Endocrinology, Vol. 13
-
Neck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO Study
Nutrients, Vol. 14, Núm. 23
-
Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome: The PREDIMED Plus Cohort
Frontiers in Endocrinology, Vol. 13
-
The Role of Nutrition on Meta-inflammation: Insights and Potential Targets in Communicable and Chronic Disease Management
Current Obesity Reports, Vol. 11, Núm. 4, pp. 305-335
2021
-
Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study
European Journal of Nutrition, Vol. 60, Núm. 4, pp. 1769-1780
-
Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study
European Journal of Nutrition, Vol. 60, Núm. 6, pp. 3043-3057
-
Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial
Liver International, Vol. 41, Núm. 7, pp. 1532-1544
-
Interactions of comorbidity and five simple environmental unhealthy habits concerning physical and mental quality of life in the clinical setting
International Journal of Environmental Research and Public Health, Vol. 18, Núm. 18